Home Contact Sitemap login Checkout
BioAlberta
  • Home
  • About
    • About
    • From The President
    • What We Do
    • Board of Directors
    • The BioAlberta Team
    • Committees
  • Industry Facts
    • Industry Facts
    • Medical Technology & Devices
    • Health Biotechnology & Pharmaceuticals
    • Agricultural Biotechnology
    • Industrial Biotechnology
    • Functional Foods & Natural Health Products
    • Environmental Biotechnology
    • Industry Terms
    • Subscribe to Our Newsletter
  • Events
    • Events
    • Annual Events & Activities
    • Archived Events
      • Archived Events
      • 2019 Events
      • 2018 Events
      • 2017 Events
      • 2016 Events
      • 2015 Events
      • 2014 Events
  • News
    • News
    • Send us your Press Release
    • News Archive
      • News Archive
      • 2019
      • 2018
      • 2017
      • 2016
      • 2015
      • 2014
  • Member Area
    • Member Area
    • Join Now
    • Member Benefits
      • Member Benefits
      • How To Access Member Benefits
    • Current Members and Life Sciences Industry
    • Current Members by Category
    • Profiled Company
      • Profiled Company
      • Previously Profiled Companies
    • Access to Funding
    • Submit a Photo
    • Job Board
      • Job Board
      • Post a Job
    • Hall Of Fame
  • Publications
    • Publications
    • A Blueprint for Success
    • Bioindustrial Directory 2019
    • HEMP Directory 2019
    • FFNHP Directory 2017
    • Bioindustrial Directory 2017
    • Other Resources
      • Other Resources
      • Archive
  • Contact
    • Contact
    • Send us Feedback
  • Send us your Press Release
  • News Archive
    • 2019
    • 2018
    • 2017
    • 2016
    • 2015
    • 2014
Home/News/News Archive/2017 Print This Page

Ceapro Inc. Announces the Launch of its Proprietary Line of Cosmeceutical Products, JUVENTE


EDMONTON, ALBERTA--(Oct. 26, 2017)

  • Successful execution of JuventeDC Inc. acquisition marks an important step in Ceapro's strategic market diversification business plan.
  • New anti-aging skin care product line represents $5B market opportunity and utilizes Ceapro's active ingredients beta glucan and avenanthramides.

 

Ceapro Inc., a growth-stage biotechnology company focused on the development and commercialization of active ingredients for healthcare and cosmetic industries, announced recently its entry into the end-user cosmeceuticals market through the acquisition of Quebec-based company, JuventeDC Inc.  Mr. Jean-Guy Boulet, Founder of Juvente, will join Ceapro as General Manager of this newly-formed, fully-owned subsidiary of Ceapro.

 

Gilles Gagnon, M.Sc., MBA, President and CEO of Ceapro, stated, "We have worked diligently over the last twelve months with different companies to evaluate opportunities to expand our product portfolio with the development of formulations that utilize our two value drivers, beta glucan and avenanthramides. Juvente successfully developed very impressive formulations, and today, we are thrilled with the completion of the acquisition of Juvente.

 

Read full press release details.

Contact Us
Suite 202
10055 - 106 Street NW
Edmonton, Alberta T5J 2Y2
Canada
Ph:  780.425.3804
Fx:  780.409.9263
admin@BioAlberta.com
Quick Links
Home
About
Industry Facts
News
Events
Member Area
Publications
Contact
Return Policy
Privacy
Terms of Use
Connect
BioAlberta: Twitter linkBioAlberta: linkedin linkBioAlberta: facebook link